MedElevator Войти в исследования
← Поиск публикаций

DOI 10.23736/s2724-5985.22.03139-4

Медицинская библиотека · Minerva gastroenterology · 2022

Noninvasive biomarkers of non-alcoholic fatty liver disease in patients with metabolic syndrome: insights from the RESOLVE Study.

Ennequin Gaël, Buchard Benjamin, Pereira Bruno, Bonjean Line, Courteix Daniel, Lesourd Bruno, Chapier Robert, Obert Philippe, Vinet Agnes, Walther Guillaume, Zak Marek, Bagheri Reza, Ugbolue Chris U, Abergel Armand, Dutheil Frédéric, Thivel David

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The aim of the present study was to evaluate: 1) the presence of liver steatosis using Fatty Liver Index (FLI), Hepatic Steatosis Index (HSI) and Liver Fat Score (LFS) in patients suffering from metabolic syndrome (MS); and 2) the association of FLI, HSI and LFS with the cardiometabolic risks.

METHODS

A total of 91 patients with MS (39 men, 52 women) and 44-age matched healthy subjects (control; 23 men and 21 women) were enrolled in the study. A continuous cardiometabolic score (MetsScore) and the noninvasive tests of hepatic steatosis were calculated for comparison and association analysis.

RESULTS

Liver steatosis was detected in 86%, 84% and 80% of people diagnosed with MS using FLI, HSI and LFS respectively and MetsScore increases with FLI severity (P<0.05). Also, FLI and LFS were positively associated with MetsScore (P<0.01 and P<0.05 respectively) but not HSI. Multivariate linear regression models revealed that FLI has a stronger association with MetsScore compared with HSI and LFS (P<0.001).

CONCLUSIONS

FLI is associated with the severity of MS and represent a good indicator to assess the relation between liver steatosis and a cardiometabolic disorders in clinical routine.

Для цитирования: Ennequin Gaël, Buchard Benjamin, Pereira Bruno, Bonjean Line, Courteix Daniel, Lesourd Bruno, Chapier Robert, Obert Philippe, Vinet Agnes, Walther Guillaume, Zak Marek, Bagheri Reza, Ugbolue Chris U, Abergel Armand, Dutheil Frédéric, Thivel David. Noninvasive biomarkers of non-alcoholic fatty liver disease in patients with metabolic syndrome: insights from the RESOLVE Study.. Minerva gastroenterology. 2022. DOI: 10.23736/s2724-5985.22.03139-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.